168 related articles for article (PubMed ID: 20527227)
21. Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas.
Sivridis E; Giatromanolaki A; Anastasiadis P; Georgiou L; Gatter KC; Harris AL; Bicknell R; Koukourakis MI;
J Pathol; 2002 Apr; 196(4):416-22. PubMed ID: 11920737
[TBL] [Abstract][Full Text] [Related]
22. RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
Liu S; Lin M; Ji H; Ding J; Zhu J; Ma R; Meng F
Diagn Pathol; 2019 Jan; 14(1):7. PubMed ID: 30684972
[TBL] [Abstract][Full Text] [Related]
23. Mixed endometrial stromal and smooth muscle tumors of the uterus: a clinicopathologic study of 15 cases.
Oliva E; Clement PB; Young RH; Scully RE
Am J Surg Pathol; 1998 Aug; 22(8):997-1005. PubMed ID: 9706980
[TBL] [Abstract][Full Text] [Related]
24. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
Fadare O; Parkash V
Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
[TBL] [Abstract][Full Text] [Related]
25. [Expression and clinical significance of ADAM19 in endometrial carcinoma].
Ou Qz; Zhang Y; Yu L; Dong Y; Zhu C; Liao Qp
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):165-9. PubMed ID: 18458692
[TBL] [Abstract][Full Text] [Related]
26. Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness.
Navarro D; Cabrera JJ; León L; Chirino R; Fernández L; López A; Rivero JF; Fernández P; Falcón O; Jiménez P
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):589-96. PubMed ID: 1562530
[TBL] [Abstract][Full Text] [Related]
27. The clinicopathologic significance of the loss of BAF250a (ARID1A) expression in endometrial carcinoma.
Zhang ZM; Xiao S; Sun GY; Liu YP; Zhang FH; Yang HF; Li J; Qiu HB; Liu Y; Zhang C; Kang S; Shan BE
Int J Gynecol Cancer; 2014 Mar; 24(3):534-40. PubMed ID: 24557437
[TBL] [Abstract][Full Text] [Related]
28. Expression of phosphatase and tensin homologue in imprint smears of endometrial carcinoma.
Kosmas K; Mitropoulou G; Provatas I; Stamoulas M; Marouga A
Cytopathology; 2018 Dec; 29(6):558-564. PubMed ID: 30007089
[TBL] [Abstract][Full Text] [Related]
29. Flotillin-1 protein is upregulated in human endometrial cancer and localization shifts from epithelial to stromal with increasing tumor grade.
Winship AL; Rainczuk K; Dimitriadis E
Cancer Invest; 2016; 34(1):26-31. PubMed ID: 26682635
[TBL] [Abstract][Full Text] [Related]
30. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer.
Song H; Li C; Lu R; Zhang Y; Geng J
Int J Gynecol Cancer; 2010 Oct; 20(7):1188-96. PubMed ID: 21495225
[TBL] [Abstract][Full Text] [Related]
31. Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.
Deng L; Gao Y; Li X; Cai M; Wang H; Zhuang H; Tan M; Liu S; Hao Y; Lin B
J Exp Clin Cancer Res; 2015 Sep; 34(1):96. PubMed ID: 26362938
[TBL] [Abstract][Full Text] [Related]
32. Tenascin expression in normal, hyperplastic, and neoplastic endometrium.
Sedele M; Karaveli S; Peştereli HE; Simşek T; Elpek G; Uner M; Sargin CF
Int J Gynecol Pathol; 2002 Apr; 21(2):161-6. PubMed ID: 11917226
[TBL] [Abstract][Full Text] [Related]
33. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
[TBL] [Abstract][Full Text] [Related]
34. [Small cell structured cell nests of endometrial stroma].
Melcher B; Vieth M; Maier H
Pathologe; 2015 Nov; 36(6):594-6. PubMed ID: 26438357
[TBL] [Abstract][Full Text] [Related]
35. Stromal cells of endometrial carcinoma promotes proliferation of epithelial cells through the HGF/c-Met/Akt signaling pathway.
Li M; Xin X; Wu T; Hua T; Wang H; Wang H
Tumour Biol; 2015 Aug; 36(8):6239-48. PubMed ID: 25775951
[TBL] [Abstract][Full Text] [Related]
36. Expression of DJ-1 in endometrial cancer: close correlation with clinicopathological features and apoptosis.
Shu K; Xiao Z; Long S; Yan J; Yu X; Zhu Q; Mei T
Int J Gynecol Cancer; 2013 Jul; 23(6):1029-35. PubMed ID: 23727824
[TBL] [Abstract][Full Text] [Related]
37. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
38. Hepatocyte growth factor/Met system promotes endometrial and endometriotic stromal cell invasion via autocrine and paracrine pathways.
Yoshida S; Harada T; Mitsunari M; Iwabe T; Sakamoto Y; Tsukihara S; Iba Y; Horie S; Terakawa N
J Clin Endocrinol Metab; 2004 Feb; 89(2):823-32. PubMed ID: 14764801
[TBL] [Abstract][Full Text] [Related]
39. NAC1, a potential stem cell pluripotency factor expression in normal endometrium, endometrial hyperplasia and endometrial carcinoma.
Ishikawa M; Nakayama K; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K
Int J Oncol; 2010 May; 36(5):1097-103. PubMed ID: 20372782
[TBL] [Abstract][Full Text] [Related]
40. Glycoprotein CD44 expression in normal, hyperplasic and neoplastic endometrium. An immunohistochemical study including correlations with p53, steroid receptor status and proliferative indices (PCNA, MIB1).
Zagorianakou N; Ioachim E; Mitselou A; Kitsou E; Zagorianakou P; Stefanaki S; Makrydimas G; Agnantis NJ
Eur J Gynaecol Oncol; 2003; 24(6):500-4. PubMed ID: 14658589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
